NetScientific PLC
(“NetScientific” or the “Group”)
Grant of Options to Director
London, UK – 10 November 2015: NetScientific plc (AIM:NSCI), a transatlantic biomedical healthcare group, announces that on 9 November 2015, options over a total of 359,020 Ordinary Shares of 5p each were granted to Francois Martelet.
|
Director |
Position |
Number of Options |
Number of Options |
|
Francois Martelet |
CEO |
359,020 |
359,020 |
The options have an exercise price of 119.5 pence per share and vest on the 8 June 2018, being the third anniversary of Francois Martelet’s appointment as CEO.
– Ends –
For further information, please contact:
|
Contact Details
|
|||||||||||||||||||||||||||||||||
About NetScientific
NetScientific is a transatlantic biomedical and healthcare technology group with a differentiated investment strategy focused solely on digital health, diagnostics and therapeutics. The Group’s objective is to source, fund and commercialise companies that significantly improve the lives of people with chronic diseases.
For more information, please visit the website at www.netscientific.net.
END
RDSFSIEFUFISESF
